Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I and Pharmacologic Study of UCN-01 (NSC638850)

Trial Profile

A Phase I and Pharmacologic Study of UCN-01 (NSC638850)

Phase of Trial: Phase I

Latest Information Update: 21 May 2018

At a glance

  • Drugs UCN 01 (Primary)
  • Indications B-cell prolymphocytic leukaemia; Cancer; Chronic lymphocytic leukaemia; Follicular lymphoma; Hairy cell leukaemia; Lymphoproliferative disorders; Mantle-cell lymphoma; Marginal zone B-cell lymphoma; Non-Hodgkin's lymphoma; T-cell prolymphocytic leukaemia; Waldenstrom's macroglobulinaemia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 21 May 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top